Clinical molecular diagnosis of breast and female reproductive system tumors / 中华检验医学杂志
Chinese Journal of Laboratory Medicine
; (12): 334-340, 2023.
Article
Dans Zh
| WPRIM
| ID: wpr-995736
Responsable en Bibliothèque :
WPRO
ABSTRACT
The gynecological tumours such as Breast cancer or female reproductive system tumors are a serious threat to female health. With the development of molecular diagnosis, the genomic changes of gynecological tumours have been revealed continuously, and the diagnosis and treatment modes of tumors have gradually changed. The detection of molecular targets which potentially participated in the transformation or progress of disease has become an important section of the management of female reproductive tumors, and accurate identification of molecular targets of tumors plays an important role in disease diagnosis, monitoring of metastasis, prediction of recurrence and treatment. This review briefly discusses the risk assessment, molecular typing, targeted therapy, toxic and side effects, and prognosis evaluation of breast and female reproductive system tumors by molecular diagnosis.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Chinese Journal of Laboratory Medicine
Année:
2023
Type:
Article